Skip to main content
SpringerLink
Log in

Biochemical characteristics of cytosolic and particulate forms of protein tyrosine kinases from N-methyl-N-nitrosourea (MNU)-induced rat mammary carcinoma

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Summary

Protein tyrosine kinase (PTK) activities in methyl nitrosourea (MNU)-induced rat mammary carcinoma has been investigated by using poly (glu: tyr; 4 : 1) as an exogenous substrate. The PTK activity of the mammary carcinoma was almost equally distributed between the particulate and soluble (cytosolic) fractions at 110,000 × g. The activity of the particulate enzyme was stimulated by non-ionic detergent Triton X-100 by about 2-fold whereas the detergent had no effect on the cytosolic form. More than 60% of the particulate enzyme could be solubilized by 5% Triton X-100. Although, both particulate and cytosolic PTKs catalyzed the phosphorylation of several tyrosine containing synthetic substrates to various degrees, poly (glu: tyr; 4 : 1) was the best substrate (apparent Km, 0.7 mg/ml). Both forms of enzymes utilized ATP as the phosphoryl group donor, with an apparent Km of 40 µM. Among various divalent cations tested, Co2, Mn2 and Mg2 were able to fulfill the divalent cation requirement of both forms of the PTKs. All these cations exerted biphasic effects on the kinase activities, however, Mg2 was the most potent cation. Agents such as epidermal growth factor, insulin and platelet derived growth factor which stimulate their respective receptor-PTK activities were without effect on the PTK activities of mammary carcinoma. On the other hand, though heparin and quercetin inhibited both enzyme activities in a concentration dependent manner, the particulate form was more sensitive to inhibition than the cytosolic form. These data indicate that MNU-induced rat mammary carcinoma expresses both particulate and cytosolic forms of PTKs and that there are significant differences in the properties of the two forms of PTKs. Differential effects of some agents on mammary carcinoma PTKs suggest that these enzymes may be acutely regulated in vivo and could play an important role in mammary carcinogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

PTK:

Protein Tyrosine Kinase

EGF:

Epidermal Growth Factor

PDGF:

Platelet Derived Growth Factor

References

  1. Hunter T, Sefton BM: Transforming gene product of rous sarcoma virus phosphorylates tyrosine. Proc Natl Acad Sci USA 77: 1311–1315, 1980

    Google Scholar 

  2. Hunter T, Cooper JA: Protein tyrosine kinases. Ann Rev Biochem 54: 897–930, 1985

    Google Scholar 

  3. Yarden Y, Ullrich A: Growth factor receptor tyrosine kinases. Ann Rev Biochem 57: 443–478, 1988

    Google Scholar 

  4. Swarup G, Dasgupta JD, Garbers DL: Tyrosine protein kinase activity of rats spleen and other tissues. J Biol Chem 258: 10341–10347, 1983

    Google Scholar 

  5. Hunter T: A thousand and one protein kinases. Cell 50: 823–829, 1987

    Google Scholar 

  6. Srivastava AK: Non-receptor protein tyrosine kinases of normal tissues. Int J Biochem 22: 1229–1234, 1990

    Google Scholar 

  7. Hanks SK, Quinn AM, Hunter T: The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science 241: 42–52, 1988

    CAS  PubMed  Google Scholar 

  8. Levy JB, Brugge JS: Biological and biochemical properties of the c-src+ gene product overexpressed in chicken embryo fibroblasts. Mol Cell Biol 9: 3332–3341, 1989

    Google Scholar 

  9. Sudol M, Kuo CF, Shigimitsu L, Alvarez-Buylla A: Expression of the yes proto-oncogene in cerebellar purkinje cells. Mol Cell Biol 9: 4545–4549, 1989

    Google Scholar 

  10. Tamura S, Suzuki Y, Kikuchi K, Hatayama I, Sato K, Hirai R, Tsuiki S: Tyrosine protein kinase in preneoplastic and neoplastic rat liver. Arch Biochem Biophys 265: 373–380, 1988

    Google Scholar 

  11. Golden A, Nemeth SP, Brugge JS: Blood platelets express high levels of pp60c-src specific tyrosine kinase activity. Proc Natl Acad Sci USA 83: 8521–8526, 1986

    Google Scholar 

  12. Snyder MA, Bishop JM, McGrath JP, Levinson AD: A mutation at the ATP-binding site of pp60v-src aoblishes kinase activity, transformation and tumorigenicity. Mol Cell Biol 5: 1772–1779, 1985

    Google Scholar 

  13. Chou CK, Dull TJ, Russell DS, Gherzi R, Lebwohl D, Ullrich A, Rosen OM: Human insulin receptors mutated at the ATP binding site lack protein tyrosine kinase activity and fail to mediate post-receptor effects of insulin. J Biol Chem 262: 1842–1847, 1987

    Google Scholar 

  14. Chen WS, Lazar CS, Poenie M, Tsien RY, Gill GN, Rosenfeld MG: Requirement for intrinsic protein tyrosine kinase in the immediate and late action os EGF receptor. Nature 328: 820–823, 1987

    Article  CAS  PubMed  Google Scholar 

  15. Hennipman A, van Oirschot BA, Smits J, Rijksen G, Staal GEJ: Tyrosine kinase activity in breast cancer, benign breast disease and normal breast tissue. Cancer Res 49: 516–521, 1989

    Google Scholar 

  16. Lacroix A, Doskas C, Bhat PV: Inhibition of growth of established N-Methyl-N-nitrosourea-induced mammary cancer in rats by retinoic acid and ovariectomy. Cancer Res 50: 5731–5734, 1990

    Google Scholar 

  17. Srivastava AK: Streptozotocin-induced diabetes decreases the cyclic AMP binding activity of the regulatory subunit of type I cAMP-dependent protein kinase from rat liver. Biochem Biophys Res Commun 117: 794–802, 1983

    Google Scholar 

  18. Braun S, Raymond WE, Racker E. Synthetic tyrosine polymers as substrates and inhibitors of tyrosine-specific protein kinases. J Biol Chem 259: 2051–2054, 1984

    Google Scholar 

  19. Kobayashi T, Nakamura S-I, Taniguchi and Yamamura H: Purification and characterization of a cytosolic protein tyrosine kinase from porcine spleen. Eur J Biochem 188: 535–540, 1990

    Google Scholar 

  20. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248–254, 1976

    Article  CAS  PubMed  Google Scholar 

  21. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680–685, 1970

    PubMed  Google Scholar 

  22. Rees-Jones RW, Hendricks SA, Quarum M, Roth J: The insulin receptor of rat brain is coupled to tyrosine kinase activity. J Biol Chem 259: 3470–3474, 1984

    Google Scholar 

  23. Zick Y, Grunberger G, Rees-Jones RW, Corri RJ: Use of tyrosine containing polymers to characterize the substrate specificity of insulin and other hormone-stimulated tyrosine kinases. Eur J Biochem 148: 177–182, 1985

    Google Scholar 

  24. Roskoski Jr R: Assays of protein kinase. Methods in Enzymol 99: 3–6, 1983

    Google Scholar 

  25. Frank DA, Sartorelli AC: Biochemical characterization of tyrosine kinase and phosphotyrosine phosphatase activities of HL-60 leukemia cells. Cancer Res 48: 4299–4306, 1988

    Google Scholar 

  26. Wong TW, Goldberg AR: Purification and characterization of the major species of tyrosine protein kinase in rat liver. J Biol Chem 259: 8505–8512, 1984

    Google Scholar 

  27. Zioncheck TF, Harrison ML, Geahlen RL: Purification and characterization of a protein tyrosine kinase from bovine thymus. J Biol Chem 261: 15637–15643, 1986

    Google Scholar 

  28. Brunati AM, Pinna LA: Characterization of four tyrosine protein kinases from the particulate fraction of rat spleen. Eur J Biochem 172: 451–457, 1988

    Google Scholar 

  29. Feder D, Bishop JM: Purification and enzymatic characterization of pp60c-src from human platelets. J Biol Chem 265: 8205–8211, 1990

    Google Scholar 

  30. Zoller MJ, Taylor SS, Sefton BM: Affinity labeling of the nucleotide binding site of the catalytic subunit of cAMP-dependent protein kinase using p-flurosulfonyl [14C] benzoyl 5′-adenosine: identification of a modified lysine residue. J Biol Chem 254: 8363–8368, 1979

    Google Scholar 

  31. Kamps MP, Taylor SS, Sefton BM: Direct evidence that oncogenic tyrosine kinases and cyclic AMP-dependent protein kinase have homologous ATP-binding sites. Nature 310: 589–592, 1984

    Google Scholar 

  32. Russo MW, Lukas TJ, Cohen S, Staros JV: Identification of residues in the nucleotide binding site of the epidermal growth factor receptor/kinase. J Biol Chem 260: 5205–5208, 1984

    Google Scholar 

  33. Srivastava AK, Chiasson J-L: Comparative characterization of receptor and non-receptor associated protein tyrosine kinases. Biochim Biophys Acta 996: 13–18, 1989

    Google Scholar 

  34. Sakai K, Sada K, Tananka Y, Kobayashi T, Nakamura SI, Yamamura H: Regulation of cytosolic protein tyrosine kinase from porcine spleen by polyamines and negative charged polysaccharides. Biochem Biophys Res Commun 154: 883–889, 1988

    Google Scholar 

  35. Glossmann H, Presek P, Eigenbrodt E: Quercetin inhibits tyrosine phosphorylation by the cyclic nucleotide independent, transforming protein kinase, pp605src. Naunyn-Schmiedeberg's Arch Pharmacol 317: 100–102, 1981

    Google Scholar 

  36. Levy J, Teuerstein I, Marbach M, Radian S, Sharoni Y: Tyrosine protein kinase activity in the DMBA-induced rat mammary tumor: inhibition by quercetin. Biochem Biophys Res Commun 123: 1227–1232, 1984

    Google Scholar 

  37. Srivastava AK: Inhibition of phosphorylase kinase and tyrosine protein kinase activities by quercetin. Biochem Biophys Res Commun 131: 1–5, 1985

    Google Scholar 

  38. Srivastava AK, Chiasson J-L: Effect of Quercetin on serine/threonine and tyrosine protein kinases. In: Cody V, Middleton E Jr, Harbone JB (Eds), Progress in Clinical and Biological Research — Plant Flavonoids in Biology and Medicine. A R Liss Inc, New York 213: 315–318, 1986

    Google Scholar 

  39. Hagiwara M, Inoue S, Tanaka T, Nuniki K, Ito M, Hidaka H: Differential effects of flavonoids as inhibitors of tyrosine protein kinases and serine/threonine protein kinases. Biochem Pharmacol 37: 2987–2992, 1988

    Article  CAS  PubMed  Google Scholar 

  40. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe SI, Itoh N, Shibuya M, Fukami Y: Genistein, a specific inhibitor of tyrosine specific protein kinases. J Biol Chem 262: 5592–5595, 1987

    Google Scholar 

  41. Shiraishi T, Domoto T, Imai N, Shimada Y, Watanabe K: Specific inhibitors of tyrosine specific protein kinase, synthetic 4-hydroxyl innamamide derivatives. Biochem Biophys Res Commun 147: 322–323, 1987

    Google Scholar 

  42. Zioncheck TF, Harrison ML, Isaacson C-C, Geahlen RL: Generation of an active protein tyrosine kinase from lymphocytes by proteolysis. J Biol Chem 263: 19195–19202, 1988

    Google Scholar 

  43. Sakai K, Nakamura S-I, Sada K, Kobayashi T, Uno H, Yamamura H: Characterization of partially purified cytosolic protein tyrosine kinase from porcine spleen. Biochem Biophys Res Commun 152: 1123–1130, 1988

    Google Scholar 

  44. Kong SK, Wang JH: Purification and characterization of a protein tyrosine kinase from bovine spleen. J Biol Chem 262: 2597–2603, 1987

    Google Scholar 

  45. Hathaway GM, Lubben TH, Traugh JA: Inhibition of casein kinase II by heparin. J Biol Chem 255: 8038–8041, 1980

    Google Scholar 

  46. Chrisman TD, Jordan JE, Exton JE: Rat liver phosphorylase kinase. J Biol Chem 256: 12981–12985, 1981

    Google Scholar 

  47. Wellstein A, Zugmaier G, Califano J, Broder S, Lippman ME: Xylanpolyhydrogensulfate inhibits fibroblast growth factor dependent growth of human tumor cells. Cancer Res 30: 583, 1989

    Google Scholar 

  48. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A, Press MF: Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244: 707–712, 1989

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Research Group on Diabetes and Metabolic Regulation, Clinical Research Institute of Montreal, Department of Medicine, University of Montreal, H2W 1R7, Montreal, Quebec, Canada

    Ashok K. Srivastava, Jean-Claude Chiasson, Jean-Louis Chiasson & Louis Windisch

  2. Laboratory of Nutrition and Cancer, Clinical Research Institute of Montreal, Department of Medicine, University of Montreal, H2W 1R7, Montreal, Quebec, Canada

    André Lacroix & Louis Windisch

Authors
  1. Ashok K. Srivastava
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jean-Claude Chiasson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jean-Louis Chiasson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. André Lacroix
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Louis Windisch
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Srivastava, A.K., Chiasson, JC., Chiasson, JL. et al. Biochemical characteristics of cytosolic and particulate forms of protein tyrosine kinases from N-methyl-N-nitrosourea (MNU)-induced rat mammary carcinoma. Mol Cell Biochem 106, 87–97 (1991). https://doi.org/10.1007/BF00231192

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00231192

Key words

Search

Navigation